Xiaochen Gai Selected Research

Xiaochen Gai Research Topics

6	Neoplasms (Cancer) 04/2024 - 09/2015
3	Liver Neoplasms (Liver Cancer) 03/2024 - 01/2022
3	Carcinogenesis 03/2024 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 09/2015
1	Infections 01/2024
1	Inflammation (Inflammations) 01/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Atherosclerosis 01/2023
1	Hepatitis B 01/2022

3	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2015
3	CateninsIBA 08/2023 - 01/2022
2	RNA Precursors (Precursor, mRNA)IBA 04/2024 - 10/2023
2	Membrane Proteins (Integral Membrane Proteins)IBA 03/2024 - 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	A-Form DNA (A-DNA)IBA 04/2024
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024
1	Tumor Biomarkers (Tumor Markers)IBA 03/2024
1	TensinsIBA 03/2024
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024
1	LipopolysaccharidesIBA 01/2024
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2024
1	GalactosamineIBA 01/2024
1	NucleotidesIBA 08/2023
1	beta CateninIBA 08/2023
1	Methotrexate (Mexate)FDA LinkGeneric 08/2023
1	shikoninIBA 01/2023
1	IronIBA 01/2023
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2023
1	Pyruvate KinaseIBA 01/2023
1	Chelating AgentsIBA 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	pyrimidineIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 09/2015
1	Monoclonal AntibodiesIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 09/2015
1	Sirolimus (Rapamycin)FDA Link 09/2015

1	Drug Therapy (Chemotherapy) 08/2023
1	Therapeutics 01/2023